Literature DB >> 20456365

Extracellular matrix in multiple sclerosis lesions: Fibrillar collagens, biglycan and decorin are upregulated and associated with infiltrating immune cells.

Hema Mohan1, Markus Krumbholz, Rakhi Sharma, Sylvia Eisele, Andreas Junker, Michael Sixt, Jia Newcombe, Hartmut Wekerle, Reinhard Hohlfeld, Hans Lassmann, Edgar Meinl.   

Abstract

Extracellular matrix (ECM) proteins can modify immune reactions, e.g. by sequestering or displaying growth factors and by interacting with immune and glial cells. Here we quantified by quantitative polymerase chain reaction (qPCR) expression of 50 ECM components and 34 ECM degrading enzymes in multiple sclerosis (MS) active and inactive white matter lesions. COL1A1, COL3A1, COL5A1 and COL5A2 chains were induced strongly in active lesions and even more in inactive lesions. These chains interact to form collagen types I, III and V, which are fibrillar collagens. Biglycan and decorin, which can decorate fibrillar collagens, were also induced strongly. The fibrillar collagens, biglycan and decorin were largely found between the endothelium and astrocytic glia limitans in the perivascular space where they formed a meshwork which was closely associated with infiltrating immune cells. In active lesions collagen V was also seen in the heavily infiltrated parenchyma. Fibrillar collagens I and III inhibited in vitro human monocyte production of CCL2 (MCP-1), an inflammatory chemokine involved in recruitment of immune cells. Together, ECM changes in lesions with different activities were quantified and proteins forming a perivascular fibrosis were identified. Induced fibrillar collagens may contribute to limiting enlargement of MS lesions by inhibiting the production of CCL2 by monocytes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20456365     DOI: 10.1111/j.1750-3639.2010.00399.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  51 in total

1.  Multiple sclerosis-linked and interferon-beta-regulated gene expression in plasmacytoid dendritic cells.

Authors:  Latt Latt Aung; Andrew Brooks; Steven A Greenberg; Michael L Rosenberg; Suhayl Dhib-Jalbut; Konstantin E Balashov
Journal:  J Neuroimmunol       Date:  2012-06-09       Impact factor: 3.478

Review 2.  The innate immune system in demyelinating disease.

Authors:  Lior Mayo; Francisco J Quintana; Howard L Weiner
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

Review 3.  Pathophysiology of the brain extracellular matrix: a new target for remyelination.

Authors:  Lorraine W Lau; Rowena Cua; Michael B Keough; Sarah Haylock-Jacobs; V Wee Yong
Journal:  Nat Rev Neurosci       Date:  2013-08-29       Impact factor: 34.870

4.  Inhibitors of myelination: ECM changes, CSPGs and PTPs.

Authors:  Danielle E Harlow; Wendy B Macklin
Journal:  Exp Neurol       Date:  2013-11-04       Impact factor: 5.330

Review 5.  Tissue mechanics regulate brain development, homeostasis and disease.

Authors:  J Matthew Barnes; Laralynne Przybyla; Valerie M Weaver
Journal:  J Cell Sci       Date:  2017-01-01       Impact factor: 5.285

6.  Pathway-Focused Profiling of Oligodendrocytes Over-Expressing miR-125a-3p Reveals Alteration of Wnt and Cell-to-Cell Signaling.

Authors:  Maria P Abbracchio; Davide Lecca; Davide Marangon
Journal:  Cell Mol Neurobiol       Date:  2020-04-01       Impact factor: 5.046

7.  A Sativex(®) -like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis.

Authors:  A Feliú; M Moreno-Martet; M Mecha; F J Carrillo-Salinas; E de Lago; J Fernández-Ruiz; C Guaza
Journal:  Br J Pharmacol       Date:  2015-05-20       Impact factor: 8.739

8.  The "central vein sign" in inflammatory demyelination: The role of fibrillar collagen type I.

Authors:  Martina Absinta; Govind Nair; Maria Chiara G Monaco; Dragan Maric; Nathanael J Lee; Seung-Kwon Ha; Nicholas J Luciano; Pascal Sati; Steven Jacobson; Daniel S Reich
Journal:  Ann Neurol       Date:  2019-03-30       Impact factor: 10.422

9.  Multiple sclerosis shrinks intralesional, and enlarges extralesional, brain parenchymal veins.

Authors:  María I Gaitán; Manori P de Alwis; Pascal Sati; Govind Nair; Daniel S Reich
Journal:  Neurology       Date:  2012-12-19       Impact factor: 9.910

10.  Biglycan promotes the chemotherapy resistance of colon cancer by activating NF-κB signal transduction.

Authors:  Bin Liu; Tonghong Xu; Xinning Xu; Yuzhu Cui; Xiaojing Xing
Journal:  Mol Cell Biochem       Date:  2018-05-14       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.